My notes on agentic AI, drug discovery, and teaching
-
Druggability, ligandability, and modality choice in the AlphaFold 3 era
Druggability assessment used to ask "does this protein have a pocket?" In 2026 it asks "which of six modalities fits this target best?" A field guide.
-
How to tell a drug target matters: evidence frameworks for target–disease linkage
Target-disease association evidence is what Phase II efficacy hinges on. A practitioner's guide to 5R, GOT-IT, the omics stack, and knowledge graphs.
-
Drug target discovery: the front-of-funnel decision behind most Phase II failures
Drug target discovery is the least quantified stage of the drug pipeline and a major determinant of Phase II outcomes. Why it matters, and where ML fits.
-
What This Site Is For
A short note on InfoArk, the book, teaching, and the kinds of technical writing I plan to publish here.